News
The FDA has approved the racemic ketamine product known as KETARx (PharmaTher Holdings) for the treatment of post-surgical ...
IV Solution and Ketamine Centers of Chicago is improving its mental health services by adding new advanced treatments to its ...
2d
PsyPost on MSNKetamine’s paradox: Life-changing therapy for some, devastating addiction for othersKetamine’s rising popularity has created a paradox. While it’s hailed by some doctors as a breakthrough psychiatric treatment ...
A woman charged with selling Matthew Perry the dose of ketamine that killed him is headed for a September trial.
Results from a small study suggest ketamine’s antidepressant effects may require activation of the brain’s opioid system.
Jasveen Sangha, allegedly known to her customers as "Ketamine Queen" and accused of selling Matthew Perry the fatal dose of the drug, is set to go to trial in September ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results